跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 727 条关于
“infantile fibrosarcoma”
全部
727
临床试验
665
药物
9
机构
6
资讯
47
去年
Larotrectinib Shows High Efficacy in Pediatric Solid Tumors with NTRK Fusion
3个月前
Vcare PharmaTech's Next-Generation TRK Inhibitor Eratrectinib Wins NMPA Approval for NTRK Fusion-Positive Solid Tumors
上个月
Precision Medicine Advances in Pediatric Sarcoma: NTRK-Targeted Therapy and Multimodal Care Transform Outcomes
3个月前
Tumor-Agnostic Basket Trials Open Clinical Trial Access for Rare Cancers, Led by Larotrectinib Success in CIFS
上个月
Curcumin Shows Best Balance of Anticancer Activity and Safety Against Fibrosarcoma Cells in Comparative Study
9个月前
FDA Grants Breakthrough Therapy Designation to Adrabetadex for Infantile-Onset Niemann-Pick Disease Type C
上个月
Eton Pharmaceuticals Licenses U.S. Rights to ASN-001, a Late-Stage Topical Therapy for Moderate Infantile Hemangiomas
2个月前
Sanofi's Nexviazyme Meets All Endpoints in Phase III Baby-COMET Trial for Infantile-Onset Pompe Disease
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
OH2 Oncolytic Virus Plus HX008 Shows Promise in Advanced Sarcoma Treatment
第 1 页,共 5 页
上一页
下一页